PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
CA
501 (c) (3) organization. Received $500,000 grant in 2022. Purpose: GENERAL SUPPORT
Tracked direct giving
$0
Connections
16
Outside Spending and Dark Money
Dark money is election spending by organizations that do not disclose their donors: 501(c)(4) social welfare organizations, 501(c)(6) trade associations, and similar non-committee filers (FEC Form 5 and Form 9). Registered super PACs also make independent expenditures. But they itemize their donors with the FEC, so their spending is not dark money. Figures below are never combined with disclosed-donor totals.
IRS 990 Schedule I Grant Chain
Grants between nonprofits reported on IRS Form 990 Schedule I. Grants between organizations are one route for dark money. A nonprofit may receive a grant from one entity and then spend that money on election ads.
IRS 990 Schedule I grants given
$28,094,472
| Grantee | Amount | Tax Year | Purpose |
|---|---|---|---|
| University of California-Los Angeles | $750,146 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| Weill Medical College of Cornell Univers | $4,977,086 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| City of Hope | $333,333 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| Icahn School of Medicine at Mount Sinai | $28,755 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | $3,099,545 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| University of Southern California | $122,117 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| Fred Hutchinson Cancer Research Center | $999,377 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| J DAVID GLADSTONE INSTITUTES | $2,685,423 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| MD ANDERSON CANCER CTR-GRANTS & CONTRACT | $377,267 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| University of Pittsburgh | $256,241 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| Dana Farber Cancer Institute | $5,425,000 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| Hoover Institution | $3,582,836 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| University of Pennsylvania | $4,666,368 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| MEMORIAL SLOAN KETTERING CANCER CENTER | $167,500 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| WASHINGTON UNIVERSITY IN ST LOUIS | $623,478 | 2024 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
IRS 990 Schedule I grants received
$500,000
| Grantor | Amount | Tax Year | Purpose |
|---|---|---|---|
| THE UCLA FOUNDATION | $500,000 | 2022 | GENERAL SUPPORT |
Source: IRS Form 990 Schedule I (Grants and Other Assistance to Organizations) via ProPublica Nonprofit Explorer and IRS 990 XML e-files. Grant amounts represent the most recent filing year available.
IRS 990 data lags a year or more behind filing. Grants shown are for the stated tax year and do not establish current-cycle funding.
Methodology Disclosure
Dark money figures are derived from FEC Form 5 (independent expenditures by non-committee organizations) and Form 9 (electioneering communications). These filings capture spending on ads and election communications but do not reveal the identity of the organization's donors. QPQ totals may differ from benchmarks like the Brennan Center's estimates. QPQ includes all Form 5 filers, while some benchmarks count only a subset of non-disclosing nonprofits. Grant chain data is from IRS Form 990 Schedule I and may not include all years or all grantee organizations.
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Gave money to | University of California-Los Angeles | IRS 990 Schedule I grant of $750,146 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | Weill Medical College of Cornell Univers | IRS 990 Schedule I grant of $4,977,086 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | City of Hope | IRS 990 Schedule I grant of $333,333 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | Icahn School of Medicine at Mount Sinai | IRS 990 Schedule I grant of $28,755 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | IRS 990 Schedule I grant of $3,099,545 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | University of Southern California | IRS 990 Schedule I grant of $122,117 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | Fred Hutchinson Cancer Research Center | IRS 990 Schedule I grant of $999,377 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | J DAVID GLADSTONE INSTITUTES | IRS 990 Schedule I grant of $2,685,423 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | MD ANDERSON CANCER CTR-GRANTS & CONTRACT | IRS 990 Schedule I grant of $377,267 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | University of Pittsburgh | IRS 990 Schedule I grant of $256,241 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | Dana Farber Cancer Institute | IRS 990 Schedule I grant of $5,425,000 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | Hoover Institution | IRS 990 Schedule I grant of $3,582,836 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | University of Pennsylvania | IRS 990 Schedule I grant of $4,666,368 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | MEMORIAL SLOAN KETTERING CANCER CENTER | IRS 990 Schedule I grant of $167,500 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Gave money to | WASHINGTON UNIVERSITY IN ST LOUIS | IRS 990 Schedule I grant of $623,478 (tax year 2024). Purpose: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | Source |
| Received money from | THE UCLA FOUNDATION | IRS 990 Schedule I grant of $500,000 (tax year 2022). Purpose: GENERAL SUPPORT | Source |